Khiron Life Sciences is among the group of overvalued stocks on the TSX Venture Exchange. This means the consensus value for each stock on this list is below its current price.

This report is generated monthly. It provides the close price and target price for these companies along with the number of analysts covering the stock. Also included is the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year. Stocks in this category are generally sold to preserve capital. There may be a number of reasons why a company would be on this list. Companies with a large analyst following with a difference in price versus target are worth exploring in more detail.

More about Khiron Life Sciences Corp

Khiron Life Sciences Corp is a Canadian integrated medical cannabis company with its core operations in Colombia. It focus on developing and commercializing top quality medically-validated products and other pharmaceutical products.

Artificial intelligence at Report on Business

Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.